Abstract
Metabolites and proteins are potential biomarkers. They can be identified with the help of mass spectrometry (MS). However, measurements obtained by using MS are prone to various random and systematic errors. The sensitivity of the technology to the errors poses practical challenges, including concerns about reproducibility of the MS-based assays and the possibility of false findings. Given the sensitivity, the proper design of MS-based experiments becomes of utmost importance. In this chapter, we review the basic experimental-design tools that can be used to prevent occurrence of errors that might cause misleading findings in MS-based experiments. We also present results of an experiment aimed at investigating variability of the intensity measurements produced by a MALDI-TOF mass spectrometer. The knowledge about the potential sources of systematic and random errors is fundamental in order to properly design an MS experiment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793–795
Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
Quezada H, Guzmán-Ortiz AL, Díaz-Sánchez H et al (2017) Omics-based biomarkers: current status and potential use in the clinic. Bol Med Hosp Infant Mex 74:219–226
Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317
Roychowdhury S, Chinnaiyan AM (2016) Translating cancer genomes and transcriptomes for precision oncology. CA Cancer J Clin 66:75–88
Shehadeh LA, Hare JM (2013) Ribonucleic acid biomarkers for heart failure: is there a correlation between heart and blood transcriptomics? JACC Heart Fail 1:477–479
Hathout Y (2015) Proteomic methods for biomarker discovery and validation. Are we there yet? Expert Rev of Proteomics 12:329–331
Eidhammer I, Flikka K, Martens L, Mikalsen S-O (2007) Computational methods for mass spectrometry proteomics. John Wiley & Sons, Chichester
Datta S, Mertens BJA (eds) (2016) Statistical analysis of proteomics, metabolomics, and lipidomics data using mass spectrometry. Springer, New York
Hilario M, Kalousis A, Pellegrini C, Muller M (2006) Processing and classification of protein mass spectra. Mass Spectrom Rev 25:409–449
Ejigu BA, Valkenborg D, Baggerman G et al (2013) Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomic profiling experiments. OMICS 17:473–485
Petricoin EF III, Ardekani AM, Hitt BA et al (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572–577
Conrads TP, Fusaro VA, Ross S et al (2004) High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer 11:163–178
Baggerly KA, Morris JS, Coombes KR (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20:777–785
Gail MH (2005) Bias. In: Encyclopedia of biostatistics. Wiley, New York
Cox DR, Reid N (2000) The theory of the design of experiments. Chapman & Hall/CRC, Boca Raton
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Burzykowski, T., Claesen, J., Valkenborg, D. (2019). Experimental Design in Quantitative Proteomics. In: Evans, C., Wright, P., Noirel, J. (eds) Mass Spectrometry of Proteins. Methods in Molecular Biology, vol 1977. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9232-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9232-4_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9231-7
Online ISBN: 978-1-4939-9232-4
eBook Packages: Springer Protocols